IBEX Technologies Earnings Estimate
IBEX Technologies Earnings per Share Projection vs Actual
About IBEX Technologies Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of IBEX Technologies earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current IBEX Technologies estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as IBEX Technologies fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada. IBEX TECHS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in IBEX Stock
IBEX Technologies financial ratios help investors to determine whether IBEX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IBEX with respect to the benefits of owning IBEX Technologies security.